[Multi-class discrimination of lymphadenopathy by using dual-modal ultrasound radiomics with elastography and B-mode

Jie Shi1, Jianwei Jiang2, Wanying Chang2

  • 1The SMART (Smart Medicine and AI-based Radiology Technology) Lab, Institute of Biomedical Engineering, School of Communication and Information Engineering, Shanghai University, Shanghai 200444, P.R.China;Shanghai Institute for Advanced Communication and Data Science, Shanghai University, Shanghai 200444, P.R.China.

Insights

Radiomics analysis of dual-modal ultrasound images aids in differentiating lymphadenopathy. This approach shows promise for distinguishing benign, lymphoma, and metastatic lymph nodes in clinical settings.

Area of Science:

  • Medical Imaging
  • Radiology
  • Oncology

Background:

  • Lymphadenopathy diagnosis can be challenging, requiring accurate differentiation between benign, lymphoma, and metastatic conditions.
  • Ultrasound elastography and B-mode imaging offer complementary information for lymph node assessment.

Purpose of the Study:

  • To evaluate the diagnostic performance of radiomics in multi-class discrimination of lymphadenopathy using combined elastography and B-mode ultrasound.
  • To assess the utility of radiomic features for classifying benign, lymphoma, and metastatic lymph nodes.

Main Methods:

  • Retrospective analysis of 251 lymph nodes from 248 patients using dual-modal ultrasound.
  • Extraction of radiomic features (shape, intensity, texture) from ultrasound images.
  • Application of information-theory-based feature selection and support vector machine classification, with Adaboost fusion.

Main Results:

  • Achieved an accuracy of 76.09%±1.41% and an overall F1 score of 75.88%±4.32% using five-fold cross-validation.
  • Area under the ROC curve for multi-class classification reached 0.77 (benign), 0.93 (lymphoma), and 0.84 (metastatic).

Conclusions:

  • Radiomic features derived from multimodal ultrasound images significantly benefit lymphadenopathy diagnosis.
  • This approach shows potential for clinical differentiation of various lymph node diseases.